Abstract：
:Transplantation faces several major obstacles that could be overcome by expression of immunomodulatory proteins through application of gene therapy techniques. Gene therapy strategies to prolong graft survival involve gene transfer of immunosuppressive or graft-protecting molecules. Very promising results have been obtained in small animal experimental models with inhibitors of co-stimulatory signals on T cells, immunosuppressive cytokines, donor major histocompatibility antigens and regulators of cell apoptosis or oxidative stress. The application of gene therapy techniques to transplantation offers a great experimental and therapeutic potential. Local production of immunosuppressive molecules may increase their therapeutic efficiency and reduce their systemic effects. When compared with other clinical situations, gene therapy in transplantation offers several potential advantages. Gene transfer into the graft can be performed ex vivo, during the transit between the donor and the recipient, thus avoiding many of the hurdles encountered with in vivo gene transfer. Furthermore, the difficulties associated with immune responses to the gene transfer vectors and transient gene expression may be easier to overcome when gene therapy protocols are applied to transplantation than when applied to other clinical situations. The next century should witness a rapid increase in the application of gene therapy techniques to large animal pre-clinical models of transplantation and later to clinical trials. Gene Therapy (2000) 7, 14-19.
journal_name
Gene Therjournal_title
Gene therapyauthors
Guillot C,Le Mauff B,Cuturi MC,Anegon Idoi
10.1038/sj.gt.3301083keywords:
subject
Has Abstractpub_date
2000-01-01 00:00:00pages
14-9issue
1eissn
0969-7128issn
1476-5462journal_volume
7pub_type
杂志文章,评审相关文献
GENE THERAPY文献大全abstract：:Adenoviral vectors deleted of E1 are attractive vehicles for in vivo gene therapy because efficient gene transfer can be achieved. Immune responses to the vector and vector-transduced cells lead to destruction of target cells, inflammation and difficulties with vector readministration. Immune effectors have been ident...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300595
更新日期：1998-03-01 00:00:00
abstract：:Glucagon-like peptide 1 (GLP-1) and its analogue exendin-4 (Ex4) have displayed potent glucose homeostasis-modulating characteristics in type 2 diabetes (T2D). However, there are few reports of effectiveness in type 1 diabetes (T1D) therapy, where there is massive loss of beta cells. We previously described a novel GL...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302944
更新日期：2007-06-01 00:00:00
abstract：:Intramuscular (i.m.) injection of a plasmid encoding human carcinoembryonic antigen (CEA) elicited immunity against transplanted syngeneic (C57BL/6) CEA-positive Lewis lung carcinoma (CEA/LLC) cells, but tumors still appeared in all mice. In wild-type mice, coinjection of an IL-12 plasmid markedly enhanced anti-CEA hu...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301274
更新日期：2000-09-01 00:00:00
abstract：:Intravenous delivery of adenoviruses is the optimal route for many gene therapy applications. Once in the blood, coagulation factor X (FX) binds to the adenovirus capsid and protects the virion from natural antibody and classical complement-mediated neutralisation in mice. However, to date, no studies have examined th...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2016.32
更新日期：2016-07-01 00:00:00
abstract：:Aptamers are oligonucleotides evolved in vitro or in nature to bind target ligands with high affinity and specificity. They are emerging as powerful tools in the fields of therapeutics, drug development, target validation and diagnostics. Aptamers are attractive alternatives to antibody- and small-molecule-based thera...
journal_title：Gene therapy
pub_type： 杂志文章,评审
doi：10.1038/sj.gt.3302900
更新日期：2007-02-01 00:00:00
abstract：:Multipotent adult progenitor cells (MAPCs) are bone marrow-derived stem cells with a high growth rate suitable for therapeutical applications as three-dimensional (3D) aggregates. Combined applications of osteogenically differentiated MAPC (OD-MAPC) aggregates and adeno-associated viral vectors (AAV) in bone bioengine...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2012.16
更新日期：2013-02-01 00:00:00
abstract：:A highly desirable feature for an human immunodeficiency virus type 1 (HIV-1) vaccine is the ability to induce broadly reactive anti-envelope antibodies that can neutralize primary HIV-1 isolates. Two immunizations with an HIV-1 envelope-encoding plasmid together with recombinant granulocyte-macrophage colony-stimulat...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302275
更新日期：2004-07-01 00:00:00
abstract：:Integration site analysis was performed on six dogs with canine leukocyte adhesion deficiency (CLAD) that survived greater than 1 year after infusion of autologous CD34+ bone marrow cells transduced with a gammaretroviral vector expressing canine CD18. A total of 387 retroviral insertion sites (RIS) were identified in...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2008.52
更新日期：2008-07-01 00:00:00
abstract：:Rescue of dystrophic skeletal muscle in mdx and utrophin/dystrophin-deficient (dko) mouse models by reintroduction of dystrophin has validated gene therapy as a potential therapeutic approach for Duchenne muscular dystrophy. However, the size of the dystrophin gene exceeds the capacity of adeno-associated viral (AAV) ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302686
更新日期：2006-05-01 00:00:00
abstract：:Cancer cachexia, characterized by anorexia, weight loss and progressive tissue wasting, has been postulated to be mediated by various cytokines. However, the precise mechanism of cachexia induction is not fully explained. We have developed synthetic double-stranded oligodeoxynucleotides (ODN) as 'decoy' cis-elements t...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300819
更新日期：1999-01-01 00:00:00
abstract：:Several of the current techniques for transfer of both oligonucleotide and plasmid DNA into the myocardium are impaired by low efficiency and toxicity. To improve gene transfer techniques, especially into the whole heart, a gene transfer method involving liposome in conjunction with a viral envelope (HVJ-liposome) was...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300750
更新日期：1998-11-01 00:00:00
abstract：:Genetic engineering of T cells for adoptive immunotherapy in cancer patients has shown significant promise. To ensure optimal antitumor activity and safety, the simultaneous expression of multiple genes is frequently required, and short viral-derived 2A sequences are increasingly preferred for this purpose. Concerns e...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2013.25
更新日期：2013-09-01 00:00:00
abstract：:Retroviral vectors are effective shuttle systems by introducing therapeutically relevant genes stably into the genome of proliferating cells. The majority of vectors applied for research or clinical applications use neomycin for cell selection and identification. To circumvent the time consuming and potentially toxic ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300384
更新日期：1997-04-01 00:00:00
abstract：:Sindbis virus expression has been used for in vitro investigations of antigen processing, presentation and epitope mapping. The recent development of a replication-deficient recombinant Sindbis virus expression vector has made in vivo expression possible with minimal pathogenic risk. Advantages of Sindbis virus over o...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300458
更新日期：1997-08-01 00:00:00
abstract：:Pancreatic cancer and chronic pancreatitis are clinical syndromes associated with severe pain that is difficult to manage. Thus, seeking additional pain reduction therapies is warranted. Excessive alcohol consumption over an extended period of time is the primary causal agent in pancreatitis. The efficacy of a replica...
journal_title：Gene therapy
pub_type： 杂志文章,评审
doi：10.1038/gt.2009.27
更新日期：2009-04-01 00:00:00
abstract：:The tumor-suppressor gene PTEN encodes a multifunctional phosphatase that is mutated in a variety of human cancers. PTEN inhibits the phosphatidylinositol 3-kinase pathway and downstream functions, including activation of Akt/protein kinase B (PKB), cell survival, and cell proliferation in tumor cells carrying mutant-...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302100
更新日期：2003-11-01 00:00:00
abstract：:Glucagon-like peptide 1 (GLP-1) is released from neuroendocrine cells in the intestine in the postprandial state and augments glucose-stimulated insulin secretion from pancreatic beta cells. To develop non-beta cells that exhibit physiologically regulated insulin secretion, we coexpressed the GLP-1 receptor and human ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302055
更新日期：2003-09-01 00:00:00
abstract：:Adoptive immunotherapy of cancer using chimeric antigen receptor (CAR)-engineered T cells with redirected specificity showed efficacy in recent trials. In preclinical models, 'second-generation' CARs with CD28 costimulatory domain in addition to CD3ζ performed superior in redirecting T-cell effector functions and surv...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2010.127
更新日期：2011-01-01 00:00:00
abstract：:Replication defective viral vectors provide a potentially useful means of gene transfer to oligodendrocytes and thus for studying the pathogenesis of white matter disease. In this study we have examined the expression pattern of E1/E3 deleted adenoviral vectors expressing the reporter gene LacZ (AdlacZ) as a means of ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300971
更新日期：1999-08-01 00:00:00
abstract：:Genetic engineering of T lymphocytes for adoptive clinical immunotherapy calls for efficient gene transduction methods. Therefore, a transient retroviral gene transduction system 'STITCH' was developed comprising pSTITCH retroviral vector encoding the transgene, plasmids encoding Moloney murine leukemia virus gag/pol ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300696
更新日期：1998-09-01 00:00:00
abstract：:betaTC-tet cells are conditionally immortalized pancreatic beta cells which can confer long-term correction of hyperglycemia when transplanted in syngeneic streptozocin diabetic mice. The use of these cells for control of type I diabetes in humans will require their encapsulation and transplantation in non-native site...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300922
更新日期：1999-06-01 00:00:00
abstract：:The failure of pharmacological approaches to cure infection with the human immunodeficiency virus (HIV) has renewed the interest in gene-based therapies. Among the various strategies that are currently explored, the blockade of HIV entry into susceptible T cells and macrophages promises to be the most powerful interve...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302755
更新日期：2006-07-01 00:00:00
abstract：:Alveolar bone loss associated with periodontal diseases is the result of osteoclastogenesis induced by bacterial pathogens. The mitogen-activated protein kinase (MAPK) phosphatase 1 (MKP-1) is a critical negative regulator of immune response as a key phosphatase capable of dephosphorylating activated MAPKs. In this st...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2010.139
更新日期：2011-04-01 00:00:00
abstract：:Mucopolysaccharidosis type IIIA (MPS-IIIA) or Sanfilippo A syndrome is a lysosomal storage genetic disease that results from the deficiency of the N-sulfoglucosamine sulfohydrolase (SGSH) protein, a sulfamidase required for the degradation of heparan sulfate glycosaminoglycans (GAGs). The accumulation of these macromo...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2014.75
更新日期：2014-12-01 00:00:00
abstract：:Cellular immunity against cancer can be achieved with viral vector- and DNA-based immunizations. In preclinical studies, cancer vaccines are very potent, but in clinical trials these potencies are not achieved yet. Thus, a rational approach to improve cancer vaccines is warranted. We previously demonstrated that the r...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2015.24
更新日期：2015-07-01 00:00:00
abstract：:Cancer therapies that target a single protein or pathway may be limited by their specificity, thus missing key players that control cellular proliferation and contributing to the failure of the treatment. We propose that approaches to cancer therapy that hit multiple targets would limit the chances of escape. To this ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/s41434-019-0096-1
更新日期：2020-02-01 00:00:00
abstract：:Nonhealing bone defects are difficult to treat. As the bone morphogenic protein and transforming growth factor beta pathways have been implicated in bone healing, we hypothesized that percutaneous Smad7 silencing would enhance signaling through both pathways and improve bone formation. Critical sized parietal trephine...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2013.15
更新日期：2013-09-01 00:00:00
abstract：:In muscle, mutant genes can be targeted and corrected directly by intramuscular (i.m.) injection of corrective DNA, or by ex vivo delivery of DNA to myogenic cells, followed by cell transplantation. Short fragment homologous replacement (SFHR) has been used to repair the exon 23 nonsense transition at the Xp21.1 dys l...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301737
更新日期：2002-06-01 00:00:00
abstract：:Glucagon-like peptide-1 (GLP-1) is an incretin hormone that performs a wide array of well-characterized antidiabetic actions, including stimulation of glucose-dependent insulin secretion, upregulation of insulin gene expression and improvements in beta-cell survival. GLP-1-receptor agonists have been developed for tre...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2009.143
更新日期：2010-02-01 00:00:00
abstract：:The mouse is widely used as a model for DNA therapy and vaccination even though the efficiency of DNA delivery in higher mammals and humans is much less. The human APOBEC3 (A3) enzymes impact viral genomes by cytidine deamination, which introduces multiple uridine residues into single-stranded DNA, a process known as ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2014.88
更新日期：2015-01-01 00:00:00
